It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The dynamics of synaptic vesicles (SVs) within presynaptic domains are tightly controlled by synapsin1 phosphorylation; however, the mechanism underlying the anchoring of synapsin1 with F-actin or SVs is not yet fully understood. Here, we found that Syn1 is modified with protein palmitoylation, and examining the roles of Syn1 palmitoylation in neurons led us to uncover that Syn1 palmitoylation is negatively regulated by its phosphorylation; together, they manipulate the clustering and redistribution of SVs. Using the combined approaches of electron microscopy and genetics, we revealed that Syn1 palmitoylation is vital for its binding with F-actin but not SVs. Inhibition of Syn1 palmitoylation causes defects in SVs clustering and a reduced number of total SVs in vivo. We propose a model in which SVs redistribution is triggered by upregulated Syn1 phosphorylation and downregulated Syn1 palmitoylation, and they reversibly promote SVs clustering. The crosstalk of Syn1 palmitoylation and phosphorylation thereby bidirectionally manipulates SVs dynamics in neurons.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China (GRID:grid.412990.7) (ISNI:0000 0004 1808 322X); Xinxiang Medical University, Institute of Psychiatry and Neuroscience, Xinxiang key laboratory of protein palmitoylation and major human diseases, Xinxiang, China (GRID:grid.412990.7) (ISNI:0000 0004 1808 322X)
2 Xinxiang Medical University, Institute of Psychiatry and Neuroscience, Xinxiang key laboratory of protein palmitoylation and major human diseases, Xinxiang, China (GRID:grid.412990.7) (ISNI:0000 0004 1808 322X)
3 Sichuan University and National Collaborative Innovation Center, Department of Urology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Chengdu, China (GRID:grid.13291.38) (ISNI:0000 0001 0807 1581)
4 The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, China (GRID:grid.412990.7) (ISNI:0000 0004 1808 322X)
5 Xinxiang Medical University, Laboratory of Genetic Regulators in the Immune System, Henan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang, China (GRID:grid.412990.7) (ISNI:0000 0004 1808 322X)